Citius Oncology (CTOR) Change in Inventory (2024 - 2026)

Citius Oncology (CTOR) has reported Change in Inventory for 3 consecutive years, with -$33645.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Inventory fell 101.8% year-over-year to -$33645.0 in Q2 2026; TTM through Jun 2026 was $4.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $12.6 million, up 492.78% from the prior year.
• Change in Inventory was -$33645.0 for Q2 2026 at Citius Oncology, down from $20248.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $6.1 million in Q4 2024 and troughed at -$33645.0 in Q2 2026.
• A 3-year average of $1.9 million and a median of $957884.0 in 2025 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory plunged 94.23% in 2025 and tumbled 101.8% in 2026, its largest moves.
• Over 3 years, Change in Inventory stood at $6.1 million in 2024, then tumbled by 94.23% to $352649.0 in 2025, then sank by 109.54% to -$33645.0 in 2026.
• The last three Change in Inventory figures came in at -$33645.0 (Q2 2026), $20248.0 (Q1 2026), and $352649.0 (Q4 2025), per Business Quant data.